C l i n i c a l m e d i c i n e

HIGHLIGHTS

• who: BMH and collaborators from the Transplantation and the University of Pennsylvania, Philadelphia, Pennsylvania, USA have published the article: C L I N I C A L M E D I C I N E, in the Journal: (JOURNAL) of April/26,/2022
• what: The authors detected decreased levels of several proinflammatory cytokines/chemokines, including CXCL10, following CSA administration compared with levels at baseline time points. The trial was conducted to determine the initial safety of using an immunosuppressive medication in a seriously ill, infected population, prior to considering potential subsequent comparative clinical investigations to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.